Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUN3 | INFLUENZA (SEASONAL) (FLUMIST) | MEDIMMUNE VACCINES, INC. | UNK | — | IN / NS |
THE REPORTER MENTIONED THAT SHE OBSERVED A CHILD BOY PATIENT TO HAVE A NOSEBLEED AFTER HAVING RECEIVED FLUMIST. SHE ASKED IF THEY COULD RECEIVE DEMONSTRATION VIDEOS ON HOW TO ADMINISTER FLUMIST TO HAVE A RESOURCE.; A spontaneous report has been received from a other health professional. The report concerns a male patient (age not provided). No medical history was reported. No concomitant products were reported. The patient received Flumist, via nasal use for vaccine/influenza prevention on an unknown date. The patient received 1 dose(s). No malfunction has been reported for the Accuspray Single Dose device. On an unknown date, the patient experienced the reporter mentioned that she observed a child boy patient to have a nosebleed after having received flumist. she asked if they could receive demonstration videos on how to administer flumist to have a resource. (preferred term: Epistaxis). The outcome of the event(s) of the reporter mentioned that she observed a child boy patient to have a nosebleed after having received flumist. she asked if they could receive demonstration videos on how to administer flumist to have a resource. was unknown. The event was considered non-serious. Device Information: Combination Product Report: Yes Product As Reported: Flumist Brand Name: FLUMIST Product Role:Suspect Device Problem code:Adverse Event Without Identified Device or Use Problem Manufacturer Name:ASTRAZENECA Labeled for single use:No Non-significant correction on 15-Oct-2025: Primary reporter information updated. Narrative amended. Insignificant correction 14-Oct-2025: Null flavor added to primary reporter. Case corrected as result of MCQC. Non-significant correction on 12-Nov-2025: Null flavor for telephone and fax removed, narrative amended.
Influenza immunisation